but after meta-analysis, there was no significant difference in any serious adverse event (e.g., death, acute cardiac insufficiency, rash dissemination, bacterial pneumonia or hematemesis) or non-serious adverse event (e.g., dizziness, nausea, vomiting, hypertension or hyperglycemia...
Findings may include headache, cranial nerve signs and symptoms (eg, dizziness, vertigo, and nausea), psychological and neurovegetative problems (eg, anxiety, depression, or sleep disturbance), and cognitive impairment (eg, memory loss and decreased ability to concentrate). [6] Imaging modalities...
Oral 0.125–0.25 mg QD Bradycardia, AVB, nausea, vomiting, visual disturbance Narrow therapeutic windowAdjust for renal failureDrug interactions via p-glycoprotein Amiodarone IV 150 mg over 10 min, followed by 1 mg/min continuous IV infusion for 6 h, then 0.5 mg/min continuous infusion...
The Edmonton Symptom Assessment System (ESAS-Revised) [34,35] is a reliable assessment tool to explore the severity of six physical (i.e., pain, tiredness, nausea, drowsiness, lack of appetite, shortness of breath), three psychological (i.e., depression, anxiety, feeling of not being wel...